Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review

Treatment with immune checkpoint inhibitors has shown efficacy against a variety of cancer types. The effects of nivolumab and pembrolizumab on lung cancer have been reported, and further therapeutic advances are ongoing. The side effects of immune checkpoint inhibitors are very different from those...

Descripción completa

Detalles Bibliográficos
Autores principales: Okura, Naoko, Asano, Mai, Uchino, Junji, Morimoto, Yoshie, Iwasaku, Masahiro, Kaneko, Yoshiko, Yamada, Tadaaki, Fukui, Michiaki, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409155/
https://www.ncbi.nlm.nih.gov/pubmed/32610470
http://dx.doi.org/10.3390/jcm9072033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409155/
https://www.ncbi.nlm.nih.gov/pubmed/32610470
http://dx.doi.org/10.3390/jcm9072033

Ejemplares similares